Trial · NCT04189133
Registered outcomes38
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 38
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Testosterone | 2 weeks after treatment start | total testosterone serum levels |
| Primary | Testosterone | 4 weeks after treatment start | total testosterone serum levels |
| Primary | Testosterone | 6 weeks after treatment start | total testosterone serum levels |
| Primary | Testosterone | 8 weeks after treatment start | total testosterone serum levels |
| Secondary | Inhibin B | 2 weeks after treatment start | Inhibin B serum levels |
| Secondary | Inhibin B | 4 weeks after treatment start | Inhibin B serum levels |
| Secondary | Inhibin B | 6 weeks after treatment start | Inhibin B serum levels |
| Secondary | Inhibin B | 8 weeks after treatment start | Inhibin B serum levels |
| Secondary | Free testosterone | 2 weeks after treatment start | Free testosterone serum levels |
| Secondary | Free testosterone | 4 weeks after treatment start | Free testosterone serum levels |
| Secondary | Free testosterone | 6 weeks after treatment start | Free testosterone serum levels |
| Secondary | Free testosterone | 8 weeks after treatment start | Free testosterone serum levels |
| Secondary | SHBG | 2 weeks after treatment start | sex hormone binding globulin (SHBG) |
| Secondary | SHBG | 4 weeks after treatment start | sex hormone binding globulin (SHBG) |
| Secondary | SHBG | 6 weeks after treatment start | sex hormone binding globulin (SHBG) |
| Secondary | SHBG | 8 weeks after treatment start | sex hormone binding globulin (SHBG) |
| Secondary | Estradiol | 2 weeks after treatment start | Estradiol serum levels by LC-MS/MS evaluation |
| Secondary | Estradiol | 4 weeks after treatment start | Estradiol serum levels by LC-MS/MS evaluation |
| Secondary | Estradiol | 6 weeks after treatment start | Estradiol serum levels by LC-MS/MS evaluation |
| Secondary | Estradiol | 8 weeks after treatment start | Estradiol serum levels by LC-MS/MS evaluation |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04189133/registered